NEW industry report: Technology and Investments - Pharma Business Study Key Findings
Reuters Events Pharma: surveyed over 260 pharmaceutical executives from across commercial and marketing, to help guide your next digital sales and technology adoption strategy.
Here’s a snapshot of the findings in this new report: 
  • 36% of respondents are “early majority” (adopt new technology after it has been successfully implemented elsewhere) and 34% “late majority” (has become mainstream) when it comes to adopting new technology.
  • 78% report an increase in their virtual sales force between 2019-22, with most 52% considering it to have a positive impact on sales.
  • 47% of companies have invested in technologies for omnichannel, with 42% of companies investing in customer relationship management (CRM technologies.
Kind regards,

Download your report here
Access findings from the survey of 260+ pharma leaders around technology and investments 
Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy:
Kana Hutton
Head, Commercial US

Reuters Events

Telephone: +44 (0) 20 7536 7281
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.